Find Locations
For hours, walk-ins and appointments.Unable to load global navigation.
Allergen Profile With Component Reflexes, Respiratory–Area 14
CPT:
82785; 86003(x24)
Test Includes
Area 14: Central California
Alternaria alternata; Aspergillus fumigatus; Bermuda grass; cat dander; cedar, mountain; Cladosporium herbarum; cockroach, German; common silver birch; Dermatophagoides farinae; Dermatophagoides pteronyssinus; dog dander; elm, American; grey alder; Immunoglobulin E, Total; maple leaf sycamore; mouse urine; mugwort; oak, white; olive tree; Penicillium chrysogenum; pigweed, rough; ragweed, short; thistle, Russian; timothy; white mulberry
If Dog IgE ≥0.35 kU/L, IgE for Can f 1, Can f 2, Can f 3 and Can f 5 will be performed.
If Cat IgE ≥0.35 kU/L, IgE for Fel d 1, Fel d 2 and Fel d 4 will be performed.
Expected Turnaround Time
3 - 5 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
|
3 - |
|
3 - 5 days |
Related Information
Related Documents
For more information, please view the literature below.
Allergy Services: Identify and Manage Patients With Allergic Disease
It Takes Two: Respiratory and Food Allergen Profiles–Area 14
Specimen Requirements
Specimen
Serum
Volume
3.5 mL
Container
Red-top tube or gel-barrier tube
Storage Instructions
Room temperature
Causes for Rejection
Inadequate labeling; gross hemolysis
Test Details
Use
Detect possible allergic responses to various substances in the environment (see Test Includes) and evaluate for hay fever, asthma, atopic eczema, and respiratory allergy. The quantitative allergen-specific IgE test is indicated (1) to determine whether an individual has elevated allergen-specific IgE antibodies; (2) if specific allergic sensitivity is needed to allow immunotherapy to be initiated; (3) when testing individuals for agents that may potentially cause anaphylaxis; (4) when evaluating individuals who are taking medication (eg, long-acting antihistamines) that may interfere with other testing modalities (eg, skin testing); (5) if immunotherapy or other therapeutic measures based on skin testing results have not led to a satisfactory remission of symptoms; (6) when an individual is unresponsive to medical management where identification of offending allergens may be beneficial.
Methodology
Thermo Fisher ImmunoCAP®
LOINC® Map
© 2021 Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.
CPT Statement/Profile Statement
The LOINC® codes are copyright © 1994-2021, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf